MILLBO BIONATURALS GROUP acquired by APHEON (EX ERGON)
Context
Ergon Capital, a mid-market private equity firm, has acquired a majority stake in the Millbo-BioNaturals Group. This deal represents a strategic play within the high-growth natural food ingredients sector, aimed at transforming a family-owned technical leader into a global institutional platform. The strategic rationale for the investment centers on leveraging Ergon’s international network and financial resources to accelerate the group's geographic expansion and to pursue a consolidation strategy in a highly fragmented market. The structure ensures strong management continuity, with the CEO and former controlling shareholder, Alessandro Boggiani, reinvesting in the business to drive the next phase of development. This transaction follows the buyer's existing sector expertise, notably its previous investment in the bakery segment.
MILLBO BIONATURALS GROUP, which reported an EBITDA margin of LOGIN in 2019, is valued in this transaction at an EV/EBITDA multiple of LOGIN, a level LOGIN than the average currently observed in the AgriFood sector (10.8x).
Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in AgriFood market trends
Target
Millbo-BioNaturals is a premier manufacturer of high-quality natural ingredients and innovative clean-label solutions for the global baking and milling industries. Headquartered in Trecate, the group operates a sophisticated industrial platform with a strong commercial presence across Europe, the United States, and the Asia-Pacific region. The company specializes in the research and production of enzymes, natural sourdoughs, and advanced bakery improvers designed to enhance the nutritional profile and shelf-life of food products without the use of chemical additives. Its business model is heavily anchored in R&D and technical innovation, serving a diverse client base ranging from artisanal bakeries to large-scale industrial food producers. By focusing on the "clean label" trend, the firm addresses the increasing consumer demand for healthy, sustainable, and transparent food supplies.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (EUR)
Similar deals in AgriFood
| Date | Acquirer | Target | Country | Sector | Deal Context |
|---|---|---|---|---|---|
| 03/2021 | LIFEBRANDS NATURAL FOOD | REVOLUTION TEA | UNITED STATES | Food Processing | LIFEBRANDS Natural Food GmbH completed the acquisition of Revolution Tea, a US‑based specialty tea company, in March 2021, marking LIFEBRANDS’ entry into the US tea and hot‑beverage market. The transaction was structured as a full‑asset or 100% ownership takeover, with Revolution Tea retaining its brand identity, Phoenix‑area presence, and founding team leadership under a new group structure. The deal brings together LIFEBRANDS’ global distribution platform and tea‑manufacturing infrastructure with Revolution Tea’s reputation for high‑quality ingredients and its established network of foodservice and retail operators |
| 02/2021 | LANXESS | EMERALD KALAMA CHEMICAL | UNITED STATES | Food Processing | LANXESS AG has signed a binding agreement to acquire 100% of the shares of Emerald Kalama Chemical from the US private equity firm American Securities LLC. This acquisition is a major strategic step for LANXESS, significantly strengthening its "Consumer Protection" segment by adding a complementary portfolio of high-margin preservatives and animal hygiene products. The deal also expands LANXESS's footprint in North America, which accounts for nearly half of the target's sales. The transaction is fully financed through LANXESS's existing liquidity and is expected to generate significant annual synergies within three years of completion |
| 12/2020 | CRONOS CAPITAL PARTNERS | EVERTON | ITALY | Food Processing | Cronos Capital Partners, alongside a group of private investors, acquired a majority stake in Everton, the Genoese tea, herbal‑infusion, and soluble‑preparation manufacturer, via a newly formed vehicle funded primarily through a substantial capital increase aimed at financing international growth and M&A activity. The operation marked a shift from full family control (held by the Dodero‑Donelli group) to a majority‑backed, partnership‑style structure, with founding shareholders Filippo and Federico Dodero remaining in top management roles alongside the existing executive team to ensure continuity |
| 11/2020 | PLATINUM EQUITY | BISCUIT INTERNATIONAL | FRANCE | Food Processing | Platinum Equity acquired a controlling stake in Biscuit International from its previous shareholders (Qualium Investissement). The transaction positions Platinum Equity to support the company's aggressive buy-and-build strategy in the fragmented European private label market. With over EUR500 million in revenue, Biscuit International serves as a scalable platform to acquire other local biscuit manufacturers across Europe, leveraging Platinum's financial resources and operational expertise. |
| 11/2020 | AMSTERDAM COMMODITIES | SUNOPTA - GLOBAL INGREDIENTS BUSINESS | NETHERLANDS | Food Processing | Amsterdam Commodities N.V. (Acomo) has acquired the Global Ingredients business of SunOpta Inc. in a debt-free, cash-free transaction. This transformative acquisition adds Tradin Organic, a global leader in organic ingredients, to Acomo's existing portfolio of conventional commodities (spices, tea, seeds). For SunOpta, the divestiture represents a strategic pivot to focus exclusively on its high-growth, plant-based food and beverage manufacturing business. The deal proceeds were used by SunOpta to pay down debt and fund capacity expansion in plant-based milk production |
| 11/2020 | RHONE CAPITAL | ILLYCAFFÈ | ITALY | Food Processing | Gruppo Illy sold a 20% minority stake in its operating company, Illycaffè SpA, to affiliates of Rhône Capital in a strategic transaction valued at around EUR 200 million. The deal was signed in November 2020 and closed in early 2021, marking the first time since the company’s founding in 1933 that Illycaffè opened its capital to a non‑family institutional investor. The transaction was structured as a minority‑stake entry, with Rhône committed to remaining a non‑controlling shareholder to support the Illy family’s long‑term stewardship |
| 10/2020 | HAUDECOEUR | PALAIS IMPÉRIAL | FRANCE | Food Processing | Haudecoeur, backed by Ergon Capital Partners and the founding family, completed the acquisition of Palais Impérial from its founders, Nicolas Pacheny and Arnaud Gillier, who reinvest alongside existing shareholders. The transaction represents a strategic bolt-on acquisition executed within the framework of Haudecoeur’s ongoing buy-and-build strategy following its primary LBO completed one year earlier. Structured as a majority investment at the group level, the deal leverages existing acquisition financing lines to support external growth initiatives |
| 08/2020 | GLANDIA NUTRITIONALS | FOODAROM | CANADA | Food Processing | Glanbia Nutritionals has acquired the Canadian flavor designer Foodarom for CAD $60 million (~USD $45 million). This acquisition aligns with Glanbia's strategy to grow its "Nutritional Solutions" (NS) division by adding complementary capabilities. Foodarom's expertise in custom flavors and masking agents is highly synergistic with Glanbia's core protein business: it allows Glanbia to sell not just the protein powder, but the entire flavored formulation (e.g., "Strawberry Whey Isolate" ready-to-mix) to its sports nutrition and lifestyle clients |
| 06/2020 | ROYAL DSM | ERBER GROUP | AUSTRIA | Food Processing | Royal DSM has reached an agreement to acquire the Erber Group, specifically its specialty animal nutrition and health businesses, Biomin and Romer Labs. Two smaller units of the Erber Group (Sanphar and EFB, representing 7% of sales) are excluded from the transaction. This acquisition provides DSM with a market-leading entry into mycotoxin risk management and expands its portfolio of high-value "Eubiotics" (gut health) solutions. The transaction is debt-financed and is expected to be earnings-enhancing in the first year |
| 01/2020 | BEMYCOMPANY CAPITAL PARTNERS | ACETAIA FONDO MONTEBELLO | ITALY | Food Processing | Bemycompany Capital Partners has acquired an initial 8% minority interest in Acetaia Fondo Montebello, with a structured agreement to increase the position to 16% within the first quarter of 2020. This investment represents a classic growth capital transaction aimed at professionalizing the target’s corporate governance and accelerating its international expansion roadmap. The strategic rationale for the deal centers on providing the target with the necessary capital and managerial expertise to establish direct commercial branches in North America and to evaluate opportunistic acquisitions of other balsamic vinegar producers |
REFERENCES
Valuation range: EV 100M - 350M EUR
Revenue range: 10M - 30M EUR
EBITDA range: 0M - 5M EUR
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of MILLBO BIONATURALS GROUP by APHEON (EX ERGON) are reserved for mynth community members. Register for free to unlock full data.
Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).
Press release: view release
Target: millbo bionaturals group
Acquirer: apheon (ex ergon)